GluR6-containing KA receptor mediates the activation of p38 MAP kinase in rat hippocampal CA1 region during brain ischemia injury

Hippocampus

Volumn 19, Issue 1, 2009, Pages 79-89

  Juan, Chen ^a   Chong, Li ^a   Dong Sheng, Pei ^a   Dong, Han ^a   Xiao Mei, Liu ^a   Hai Xia, Jiang ^a   Xiao Tian, Wang ^a   Qiu Hua, Guan ^a   Xiang Ru, Wen ^a   Xiao Yu, Hou ^a   Guang Yi, Zhang ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Brain ischemia; Glutamate receptor 6 (GluR6); Hippocampus; Mixed lineage kinase 3 (MLK3); p38 MAP kinase

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; GLUTAMATE RECEPTOR 6; KAINIC ACID RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE P38; MIXED LINEAGE KINASE 3; POSTSYNAPTIC DENSITY PROTEIN 95; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN REGION; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; HIPPOCAMPUS; HISTOLOGY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL DEGENERATION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PYRAMIDAL NERVE CELL; RAT; REPERFUSION INJURY;

ANIMALS; BRAIN INFARCTION; CELL SURVIVAL; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ENZYME ACTIVATION; ENZYME INHIBITORS; GLUTAMIC ACID; HIPPOCAMPUS; HYPOXIA-ISCHEMIA, BRAIN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MAP KINASE KINASE 3; MAP KINASE KINASE KINASES; MAP KINASE SIGNALING SYSTEM; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, KAINIC ACID; REPERFUSION INJURY; SYNAPTIC TRANSMISSION;

EID: 58149473580     PISSN: 10509631     EISSN: 10981063     Source Type: Journal    
DOI: 10.1002/hipo.20479     Document Type: Article

References (40)

1. Behrens MM, Strasser U, Koh JY, Gwag BJ, Choi DW, 1999. Prevention of neuronal apoptosis by phorbol ester-induced activation of protein kinase C: Blockade of p38 mitogen-activated protein kinase. Neuroscience 94:917-927.
2. Culbert AA, Skaper SD, Howlett DR, Evans NA, Facci L, Soden PE, Seymour ZM, Guillot F, Gaestel M, Richardson JC. 2006. MAPK-activated protein kinase 2 deficiency in microglia inhibits proinflammatory mediator release and resultant neurotoxicity. Relevance to neuroinflammation in a transgenic mouse model of Alzheimer disease, J Biol Chem 281:23658-23667.
3. Da Silva J, Pierrat B, Mary JL, Lesslauer W. 1997. Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitricoxide synthase expression in mouse astrocytes. J Biol Chem 272:28373-28380.
4. Derijard B, Raingeaud J, Barrett T, Wu IH, Han J, Ulevitch RJ, Davis RJ. 1995. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267:682-685.
5. Dingledine R, Borges K, Bowie D, Traynelis SF. 1999. The glutamate receptor ion channels, Pharmacol Rev 51:7-61.
6. Gallo KA, Mark MR, Scadden DT, Wang Z, Gu Q, Godowski PJ. 1994. Identification and characterization of SPRK, a novel srchomology 3 domain-containing proline-rich kinase with serine/threonine kinase activity. J Biol Chem 269:15092-15100.
7. Han J, Lee JD, Jiang Y, Li Z, Feng L, Ulevitch RJ. 1996. Characterization of the structure and function of a novel MAP kinase kinase (MKK6). J Biol Chem 271:2886-2891.
8. Han J, Wang X, Jiang Y, Ulevitch RJ, Lin S. 1997. Identification and characterization of a predominant isoform of human MKK3. FEBS Lett 403:19-22.
9. Harper SJ, LoGrasso P. 2001. Signalling for survival and death in neurones: The role of stress-activated kinases, JNK and p38 Cell Signal 13:299-310.
10. Hollmann M, Heinemann S. 1994. Cloned glutamate receptors. Annu Rev Neurosci 17:31-108.
11. Irving EA, Bamford M. 2002. Role of mitogen- and stress-activated kinases in ischemic injury. J Cereb Blood Flow Metab 22:631-647.
12. Kawasaki H, Morooka T, Shimohama S, Kimura J, Hirano T, Gotoh Y, Nishida E. 1997. Activation and involvement of p38 mitogenactivated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells. J Biol Chem 272:18518-18521.
13. Kim KY, Kim BC, Xu Z, Kim SJ. 2004. Mixed lineage kinase 3 (MLK3)-activated p38 MAP kinase mediates transforming growth factor-β-induced apoptosis in hepatoma cells. J Biol Chem 279:29478-29484.
14. Legos JJ, McLaughlin B, Skaper SD, Strijbos PJ, Parsons AA, Aizenman E, Herin GA, Barone FC, Erhardt JA. 2002. The selective p38 inhibitor SB-239063 protects primary neurons from mild to moderate excitotoxic injury. Eur J Pharmacol 447:37-42.
15. Leung IW, Lassam N. 2001. The kinase activation loop is the key to mixed lineage kinase-3 activation via both autophosphorylation and hematopoietic progenitor kinase 1 phosphorylation. J Biol Chem 276:1961-1967.
16. Lin A, Minden A, Martinetto H, Claret FX, Lange-Carter C, Mercurio F, Johnson GL, Karin M. 1995. Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science 268:286-290.
17. Michaelis EK. 1998. Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging. Prog Neurobiol 54:369-415.
18. Mielke K, Herdegen T. 2000. JNK and p38 stresskinases-degenerative effectors of signal-transduction-cascades in the nervous system. Prog Neurobiol 61:45-60.
19. Moriguchi T, Kuroyanagi N, Yamaguchi K, Gotoh Y, Irie K, Kano T, Shirakabe K, Muro Y, Shibuya H, Matsumoto K, et al. 1996. A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3. J Biol Chem 271:13675-13679.
20. Nakahara S, Yone K, Sakou T, Wada S, Nagamine T, Niiyama T, Ichijo H. 1999. Induction of apoptosis signal regulating kinase 1 (ASK1) after spinal cord injury in rats; Possible involvement of ASK1-JNK and -p38 pathways in neuronal apoptosis. J Neuropathol Exp Neurol 58:442-450.
21. Ozawa H, Shioda S, Dohi K, Matsumoto H, Mizushima H, Zhou CJ, Funahashi H, Nakai Y, Nakajo S, Matsumoto K. 1999. Delayed neuronal cell death in the rat hippocampus is mediated by the mitogen-activated protein kinase signal transduction pathway. Neurosci Lett 262:57-60.
22. Pan J, Zhang QG, Zhang GY. 2005. The neuroprotective effects of K252a through inhibiting MLK3/MKK7/JNK3 signaling pathway on ischemic brain injury in rat hippocampal CA1 region. Neuroscience 131:147-159.
23. Pei DS, Guan QH, Sun YF, Zhang QX, Xu TL, Zhang GY. 2005. Neuroprotective effects of GluR6 antisense oligodeoxynucleotides on transient brain ischemia/reperfusion-induced neuronal death in rat hippocampal CA1 region. J Neurosci Res 82:642-649.
24. Pei DS, Wang XT, Liu Y, Sun YF, Guan QH, Wang W, Yan JZ, Zong YY, Xu TL, Zhang GY. 2006. Neuroprotection against ischaemic brain injury by a GluR6-9c peptide containing the TAT protein transduction sequence. Brain 129 (Part 2):465-479.
25. Pulsinelli WA, Brierley JB. 1979. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 10:267-272.
26. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, Davis RJ. 1995. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270:7420-7426.
27. Raingeaud J, Whitmarsh AJ, Barrett T, Derijard B, Dans RJ. 1996. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol Cell Biol 16:1247-1255.
28. Roux PP, Dorval G, Boudreau M, Angers-Loustau A, Morris SJ, Makkerh J, Barker PA. 2002. K252a and CEP 1347 are neuroprotective compounds that inhibit mixed-lineage kinase-3 and induce activation of Akt and ERK. J Biol Chem 277:49473-49480.
29. Savinainen A, Garcia EP, Dorow D, Marshall J, Liu YF. 2001. Kainate receptor activation induces mixed lineage kinase-mediated cellular signaling cascades via post-synaptic density protein 95. J Biol Chem 276:11382-11386.
30. Seeburg PH. 1993. The TINS/TiPS lecture. The molecular biology of mammalian glutamate receptor channels. Trends Neurosci 16:359-365.
31. Stein B, Brady H, Yang MX, Young DB, Barbosa MS. 1996. Cloning and characterization of MEK6, a novel member of the mitogenactivated protein kinase kinase cascade. J Biol Chem 271:11427-11433.
32. Tian H, Zhang Q, Li H, Zhang G. 2003. Antioxidant N-acetylcysteine and AMPA/KA receptor antagonist DNQX inhibited mixed lineage kinase-3 activation following cerebral ischemia in rat hippocampus. Neurosci Res 47:47-53.
33. 2-terminal kinase 3 is mediated by the GluR6.PSD-95.MLK3 signaling module following cerebral ischemia in rat hippocampus. Brain Res 1061:57-66.
34. Tibbies LA, Ing YL, Kiefer F, Chan J, Iscove N, Woodgett JR, Lassam NJ. 1996. MLK-3 activates the SAPK/JNK and p38/RK pathways via SEK1 and MKK3/6. Embo J 15:7026-7035.
35. Verdoorn TA, Johansen TH, Drejer J, Nielsen EO. 1994. Selective block of recombinant glur6 receptors by NS-102, a novel non-NMDA receptor antagonist. Eur J Pharmacol 269:43-49.
36. Walton KM, DiRocco R, Bartlett BA, Koury E, Marcy VR, Jarvis B, Schaefer EM, Bhat RV. 1998. Activation of p38 MAPK in microglia after ischemia. J Neurochem 70:1764-1767.
37. Wang X, Xu L, Wang H, Young PR, Gaestel M, Feuerstein GZ. 2002. Mitogen-activated protein kinase-activated protein (MAPKAP) kinase 2 deficiency protects brain from ischemic injury in mice. J Biol Chem 277:43968-43972.
38. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331.
39. Yahata K, Kishine H, Sone T, Sasaki Y, Hotta J, Chesnut JD, Okabe M, Imamoto F. 2005. Multi-gene gateway clone design for expression of multiple heterologous genes in living cells: Conditional gene expression at near physiological levels. J Biotechnol 118:123-134.
40. Zhang QX, Pei DS, Guan QH, Sun YF, Liu XM, Zhang GY. 2006. Blockade of the translocation and activation of mitogen-activated protein kinase kinase 4 (MKK4) signaling attenuates neuronal damage during later ischemia-reperfusion. J Neurochem 98:170-179.